Drug treatment of refractory status epilepticus;Traitement pharmacologique de l'état de mal réfractaire

Revue Neurologique

Volumn 165, Issue 4, 2009, Pages 373-379

  Rossetti, A O ^a   Santoli, F ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Centre Hospitalier Intercommunal Andre Gregoire   (France)

Author keywords

General anesthesia; Midazolam; Propofol; Refractory status epilepticus; Thiopental; Treatment

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CORTICOSTEROID; DOPAMINE RECEPTOR STIMULATING AGENT; ETIRACETAM; GLYCINE RECEPTOR ANTAGONIST; IMMUNOGLOBULIN; INHALATION ANESTHETIC AGENT; KETAMINE; LIDOCAINE; MAGNESIUM SULFATE; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; THIOPENTAL; TOPIRAMATE; VALPROIC ACID; VERAPAMIL; HYPNOTIC SEDATIVE AGENT;

CARDIAC DEPRESSION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONVULSION; DISEASE COURSE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INHIBITION; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; EPIDEMIOLOGICAL DATA; EPILEPTIC STATE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INDUCED HYPOTENSION; LOADING DRUG DOSE; LONG TERM CARE; META ANALYSIS; MORTALITY; NEUROTOXICITY; PATHOPHYSIOLOGY; PLASMAPHERESIS; PROGNOSIS; PROSPECTIVE STUDY; RECOMMENDED DRUG DOSE; REVIEW; RHABDOMYOLYSIS; SIDE EFFECT; SYNDROME DE PERFUSION; SYSTEMATIC REVIEW; TREATMENT INDICATION; WEANING; DRUG RESISTANCE;

ANTICONVULSANTS; BARBITURATES; DRUG RESISTANCE; HUMANS; HYPNOTICS AND SEDATIVES; MIDAZOLAM; PROPOFOL; STATUS EPILEPTICUS;

EID: 66849137835     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2008.12.003     Document Type: Review

References (73)

1. Conférence de consensus en réanimation et médecine d'urgence Conférence de consensus en réanimation et médecine d'urgence : prise en charge de l'état de mal épileptique. Société de réanimation de langue franaise Rean Urg 4 1995 387 396
2. B.K. Alldredge, A.M. Gelb, S.M. Isaacs, M.D. Corry, F. Allen, and S. Ulrich A comparison of lorazepam, diazepam and placebo for the treatment of out-of-hospital status epilepticus N Engl J Med 345 2001 631 637
3. M.J. Aminoff Do nonconvulsive seizures damage the brain?-No Arch Neurol 55 1998 119 120
4. C.D. Bayliff, M.L. Schwartz, and B.G. Hardy Pharmacokinetics of high-dose pentobarbital in severe head trauma Clin Pharmacol Ther 38 1985 457 461
5. T.P. Bleck Refractory status epilepticus Curr Opin Crit Care 11 2005 117 120
6. D.J. Borris, E.H. Bertram, and J. Kapur Ketamine controls prolonged status epilepticus Epilepsy Res 42 2000 117 122
7. P. Charlesworth, I. Jacobson, and C.D. Richards Pentobarbitone modulation of NMDA receptors in neurones isolated from the rat olfactory brain Br J Pharmacol 116 1995 3005 3013
8. J.W. Chen, and C.G. Wasterlain Status epilepticus: pathophysiology and management in adults Lancet Neurol 5 2006 246 256
9. J. Claassen, L.J. Hirsch, R.G. Emerson, J.E. Bates, T.B. Thompson, and S.A. Mayer Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus Neurology 57 2001 1036 1042
10. J. Claassen, L.J. Hirsch, R.G. Emerson, and S.A. Mayer Treatment of refractory status epilepticus with pentobarbital, propofol or midazolam: a systematic review Epilepsia 43 2002 146 153
11. J. Claassen, L.J. Hirsch, and S.A. Mayer Treatment of status epilepticus: a survey of neurologists J Neurol Sci 211 2003 37 41
12. D.J. Cordato, L.E. Mather, A.S. Gross, and G.K. Herkes Pharmacokinetics of thiopental enantiomers during and following prolonged high-dose therapy Anesthesiology 91 1999 1693 1702
13. O.L. Cremer, K.G. Moons, E.A. Bouman, J.E. Kruijswijk, A.M. de Smet, and C.J. Kalkman Long-term propofol infusion and cardiac failure in adult head-injured patients Lancet 357 2001 117 118
14. F.W. Drislane Evidence against permanent neurologic damage from nonconvulsive status epilepticus J Clin Neurophysiol 16 1999 323 331 [discussion 353]
15. D. Enting, J.J. Ligtenberg, L.P. Aarts, and J.G. Zijlstra Total suppression of cerebral activity by thiopental mimicking propofol infusion syndrome: a fatal common pathway? Anesth Analg 100 2005 1864 1865 [author reply 1865]
16. N.B. Fountain, and E.W. Lothman Pathophysiology of status epilepticus J Clin Neurophysiol 12 1995 326 342
17. M. Holtkamp The anaesthetic and intensive care of status epilepticus Curr Opin Neurol 20 2007 188 193
18. M. Holtkamp, F. Masuhr, L. Harms, K.M. Einhaupl, H. Meierkord, and K. Buchheim The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists J Neurol Neurosurg Psychiatry 74 2003 1095 1099
19. M. Holtkamp, J. Othman, K. Buchheim, F. Masuhr, E. Schielke, and H. Meierkord A "malignant" variant of status epilepticus Arch Neurol 62 2005 1428 1431
20. M. Holtkamp, J. Othman, K. Buchheim, and H. Meierkord Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit J Neurol Neurosurg Psychiatry 76 2005 534 539
21. M. Holtkamp, J. Othman, K. Buchheim, and H. Meierkord Diagnosis of psychogenic nonepileptic status epilepticus in the emergency setting Neurology 66 2006 1727 1729
22. O. Hope, and H. Blumenfeld Cellular physiology of status epilepticus F.W. Drislane Status epilepticus. A clinical perspective 2005 Humana press Totowa, NJ 159 180
23. P. Iannetti, A. Spalice, and P. Parisi Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus Epilepsia 46 2005 967 969
24. V. Jevtovic-Todorovic, D.F. Wozniak, S. Powell, and J.W. Olney Propofol and sodium thiopental protect against MK-801-induced neuronal necrosis in the posterior cingulate/retrosplenial cortex Brain Res 913 2001 185 189
25. K.G. Jordan, and L.J. Hirsch In nonconvulsive status epilepticus (NCSE), treat to burst-suppression: pro and con Epilepsia 47 2006 41 45
26. P.W. Kaplan No, some types of nonconvulsive status epilepticus cause little permanent neurologic sequelae (or: "the cure may be worse than the disease") Neurophysiol Clin 30 2000 377 382
27. S. Knake, J. Gruener, K. Hattemer, K.M. Klein, S. Bauer, and W.H. Oertel Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus J Neurol Neurosurg Psychiatry 79 2008 588 589
28. H.G. Kress, and R. Segmuller Intravenous anesthetics and human neutrophil granulocyte motility in vitro Anaesthesist 36 1987 356 361
29. K.B. Krishnamurthy, and F.W. Drislane Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus Epilepsia 37 1996 863 867
30. K.B. Krishnamurthy, and F.W. Drislane Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus Epilepsia 40 1999 759 762
31. Leppert D, Stöckli HR, Fuhr P. Directives pour le traitement de l'état de mal épileptique. Schweizerische Aerztezeitung 2005;86. http://www.saez.ch/status-epilepticus-f.pdf. (Consulté le 16 février 2009).
32. I.E. Leppik, A.T. Derivan, R.W. Homan, J. Walker, R.E. Ramsay, and B. Patrick Double-blind study of lorazepam and diazepam in status epilepticus JAMA 249 1983 1452 1454
33. D.H. Lowenstein The management of refractory status epilepticus: an update Epilepsia 47 2006 35 40
34. D.H. Lowenstein, and B.K. Alldredge Status epilepticus N Engl J Med 338 1998 970 976
35. P.E. Marik Propofol: therapeutic indications and side-effects Curr Pharm Des 10 2004 3639 3649
36. S.A. Mayer, J. Claassen, J. Lokin, F. Mendelsohn, L.J. Dennis, and B.F. Fitzsimmons Refractory status epilepticus: frequency, risk factors and impact on outcome Arch Neurol 59 2002 205 210
37. T.A. Milligan, and E.B. Bromfield Severely refractory status epilepticus: etiologies and outcomes Neurology 68 2007 A379
38. F. Minicucci, G. Muscas, E. Perucca, G. Capovilla, F. Vigevano, and P. Tinuper Treatment of status epilepticus in adults: guidelines of the Italian League against Epilepsy Epilepsia 47 2006 9 15
39. S.M. Mirsattari, M.D. Sharpe, and G.B. Young Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane Arch Neurol 61 2004 1254 1259
40. D.K. Naritoku, and S. Sinha Prolongation of midazolam half-life after sustained infusion for status epilepticus Neurology 54 2000 1366 1368
41. B.A. Orser, M. Bertlik, L.Y. Wang, and J.F. MacDonald Inhibition by propofol (2,6 di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones Br J Pharmacol 116 1995 1761 1768
42. H. Outin, P. Liot, B. De Jonghe, and P. Thomas Management of adult refractory convulsive status epilepticus in the intensive care unit Rev Neurol (Paris) 158 2002 1059 1068
43. T.J. Parke, J.E. Stevens, A.S. Rice, C.L. Greenaway, R.J. Bray, and P.J. Smith Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports BMJ 305 1992 613 616
44. I. Parviainen, A. Uusaro, R. Kalviainen, E. Kaukanen, E. Mervaala, and E. Ruokonen High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit Neurology 59 2002 1249 1251
45. I. Parviainen, A. Uusaro, R. Kalviainen, E. Mervaala, and E. Ruokonen Propofol in the treatment of refractory status epilepticus Intensive Care Med 32 2006 1075 1079
46. A. Prasad, B.B. Worrall, E.H. Bertram, and T.P. Bleck Propofol and midazolam in the treatment of refractory status epilepticus Epilepsia 42 2001 380 386
47. T.K. Robakis, and L.J. Hirsch Literature review, case report and expert discussion of prolonged refractory status epilepticus Neurocrit Care 4 2006 35 46
48. M.A. Rogawski, and W. Loscher The neurobiology of antiepileptic drugs Nat Rev Neurosci 5 2004 553 564
49. A.O. Rossetti, and E.B. Bromfield Determinants of success in the use of oral levetiracetam in status epilepticus Epilepsy Behav 8 2006 651 654
50. A.O. Rossetti, G. Logroscino, and E.B. Bromfield Refractory status epilepticus: effect of treatment aggressiveness on prognosis Arch Neurol 62 2005 1698 1702
51. A.O. Rossetti, G. Logroscino, and E.B. Bromfield A clinical score for prognosis of status epilepticus in adults Neurology 66 2006 1736 1738
52. A.O. Rossetti, M.D. Reichhart, M.D. Schaller, P.A. Despland, and J. Bogousslavsky Propofol treatment of refractory status epilepticus: a study of 31 episodes Epilepsia 45 2004 757 763
53. S. Ruegg, Y. Naegelin, M. Hardmeier, D.T. Winkler, S. Marsch, and P. Fuhr Intravenous levetiracetam: treatment experience with the first 50 critically ill patients Epilepsy Behav 12 2008 477 480
54. S.J. Ruegg, and M.A. Dichter Diagnosis and treatment of nonconvulsive status epilepticus in an intensive care unit setting Curr Treat Options Neurol 5 2003 93 110
55. R.D. Sheth, and B.E. Gidal Refractory status epilepticus: response to ketamine Neurology 51 1998 1765 1766
56. S. Shorvon The management of status epilepticus J Neurol Neurosurg Psychiatry 70 2001 I122 I127
57. M.M. Stecker, T.H. Kramer, E.C. Raps, R. O'Meeghan, E. Dulaney, and D.J. Skaar Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings Epilepsia 39 1998 18 26
58. A.R. Towne, L.K. Garnett, E.J. Waterhouse, L.D. Morton, and R.J. DeLorenzo The use of topiramate in refractory status epilepticus Neurology 60 2003 332 334
59. D. Treiman Effective treatment for status epilepticus D. Schmidt S. Schachter Epilepsy problem solving in clinical practice 2000 Martin Dunitz London, UK 253 265
60. D. Treiman, N. Walton, and J. Collins Treatment of status epilepticus if first drug fails Epilepsia 40 1999 243
61. D.M. Treiman, P.D. Meyers, N.Y. Walton, J.F. Collins, C. Colling, and A.J. Rowan A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group N Engl J Med 339 1998 792 798
62. E.E. Ubogu, S.M. Sagar, A.J. Lerner, B.N. Maddux, J.I. Suarez, and M.A. Werz Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity Epilepsy Behav 4 2003 70 75
63. P.C. Van Ness Pentobarbital and EEG burst-suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin Epilepsia 31 1990 61 67
64. K. van Rijckevorsel, P. Boon, H. Hauman, B. Legros, M. Ossemann, and B. Sadzot Standards of care for non-convulsive status epilepticus: Belgian consensus recommendations Acta Neurol Belg 106 2006 117 124
65. B. Vasile, F. Rasulo, A. Candiani, and N. Latronico The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome Intensive Care Med 29 2003 1417 1425
66. B. Walder, M.R. Tramer, and M. Seeck Seizure-like phenomena and propofol: a systematic review Neurology 58 2002 1327 1332
67. A. Wessen, P.M. Persson, A. Nilsson, and P. Hartvig Clinical pharmacokinetics of propofol given as a constant-rate infusion and in combination with epidural blockade J Clin Anesth 6 1994 193 198
68. E.F.M. Wijdicks Status epilepticus E.F.M. Wijdicks The clinical practice of critical care neurology 2003 Oxford University Press New York, NY 389 402
69. O.H. Wilder-Smith, P.A. Ravussin, L.A. Decosterd, P.A. Despland, and B. Bissonnette Midazolam premedication reduces propofol dose requirements for multiple anesthetic endpoints Can J Anaesth 48 2001 439 445
70. Working Group on Status Epilepticus Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's JAMA 270 1993 854 859
71. G.B. Young, and K.G. Jordan Do nonconvulsive seizures damage the brain?-Yes Arch Neurol 55 1998 117 119
72. E.L. Zarovnaya, B.C. Jobst, and B.T. Harris Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus Epilepsia 48 2007 1002 1006
73. R.Z. Zhan, S. Qi, C. Wu, H. Fujihara, K. Taga, and K. Shimoji Intravenous anesthetics differentially reduce neurotransmission damage caused by oxygen-glucose deprivation in rat hippocampal slices in correlation with N-methyl-D-aspartate receptor inhibition Crit Care Med 29 2001 808 813